Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
NCT00002783 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2013-07-03
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surgery in treating patients with high-risk stomach cancer.
Conditions
Interventions
- DRUG
- DRUG
-
floxuridine
- DRUG
- DRUG
-
leucovorin calcium
- PROCEDURE
-
conventional surgery
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
David Paul Kelsen, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-05-31
- Primary Completion
- 2001-01-31
- Completion
- 2001-01-31
Countries
- United States
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
NCT00004873 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
NCT01928290 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
NCT00003237 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery
NCT00448682 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
NCT00011960 ·Status: COMPLETED ·Phase: PHASE2
-
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction
NCT01360086 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
NCT00711243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
NCT00003172 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
NCT00515411 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
NCT00003862 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
NCT00084617 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
NCT00003298 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
NCT00103103 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
NCT05296005 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
NCT00591045 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer
NCT01851941 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
NCT00004099 ·Status: TERMINATED ·Phase: PHASE3
-
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)
NCT00525785 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
NCT07018063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
NCT00982592 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
NCT04931420 ·Status: WITHDRAWN ·Phase: PHASE2
-
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
NCT00134095 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
NCT00005060 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT05702229 ·Status: RECRUITING ·Phase: PHASE2